BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 29788780)

  • 1. Isoform selectivity of harmine-conjugated 1,2,3-triazoles against human monoamine oxidase.
    Haider S; Alhusban M; Chaurasiya ND; Tekwani BL; Chittiboyina AG; Khan IA
    Future Med Chem; 2018 Jun; 10(12):1435-1448. PubMed ID: 29788780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-Based Design and Synthesis of Harmine Derivatives with Different Selectivity Profiles in Kinase versus Monoamine Oxidase Inhibition.
    Bálint B; Wéber C; Cruzalegui F; Burbridge M; Kotschy A
    ChemMedChem; 2017 Jun; 12(12):932-939. PubMed ID: 28264138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How to Separate Kinase Inhibition from Undesired Monoamine Oxidase A Inhibition-The Development of the DYRK1A Inhibitor AnnH75 from the Alkaloid Harmine.
    Wurzlbauer A; Rüben K; Gürdal E; Chaikuad A; Knapp S; Sippl W; Becker W; Bracher F
    Molecules; 2020 Dec; 25(24):. PubMed ID: 33339338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of harmine and β-carboline analogs from a high-throughput screen of an approved drug collection; profiling as differential inhibitors of DYRK1A and monoamine oxidase A and for in vitro and in vivo anti-cancer studies.
    Tarpley M; Oladapo HO; Strepay D; Caligan TB; Chdid L; Shehata H; Roques JR; Thomas R; Laudeman CP; Onyenwoke RU; Darr DB; Williams KP
    Eur J Pharm Sci; 2021 Jul; 162():105821. PubMed ID: 33781856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of 4-substituted 1,2,3-triazoles as novel oxazolidinone antibacterial agents with reduced activity against monoamine oxidase A.
    Reck F; Zhou F; Girardot M; Kern G; Eyermann CJ; Hales NJ; Ramsay RR; Gravestock MB
    J Med Chem; 2005 Jan; 48(2):499-506. PubMed ID: 15658863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of 3-Hydroxy-3-phenacyloxindole Analogues of Isatin as Potential Monoamine Oxidase Inhibitors.
    Tripathi RK; Krishnamurthy S; Ayyannan SR
    ChemMedChem; 2016 Jan; 11(1):119-32. PubMed ID: 26592797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SAR and molecular mechanism studies of monoamine oxidase inhibition by selected chalcone analogs.
    Shalaby R; Petzer JP; Petzer A; Ashraf UM; Atari E; Alasmari F; Kumarasamy S; Sari Y; Khalil A
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):863-876. PubMed ID: 30915862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid synthesis of flavone-based monoamine oxidase (MAO) inhibitors targeting two active sites using click chemistry.
    Jia WZ; Cheng F; Zhang YJ; Ge JY; Yao SQ; Zhu Q
    Chem Biol Drug Des; 2017 Jan; 89(1):141-151. PubMed ID: 27666135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenging the anticolorectal cancer capacity of quinoxaline-based scaffold via triazole ligation unveiled new efficient dual VEGFR-2/MAO-B inhibitors.
    Ayoup MS; Ammar A; Abdel-Hamid H; Amer A; Abu-Serie MM; Nasr SA; Ghareeb DA; Teleb M; Tageldin GN
    Bioorg Chem; 2024 Feb; 143():107102. PubMed ID: 38211551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond topoisomerase inhibition: antitumor 1,4-naphthoquinones as potential inhibitors of human monoamine oxidase.
    Coelho-Cerqueira E; Netz PA; do Canto VP; Pinto AC; Follmer C
    Chem Biol Drug Des; 2014 Apr; 83(4):401-10. PubMed ID: 24165164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective inhibition of monoamine oxidase A by chelerythrine, an isoquinoline alkaloid.
    Baek SC; Ryu HW; Kang MG; Lee H; Park D; Cho ML; Oh SR; Kim H
    Bioorg Med Chem Lett; 2018 Aug; 28(14):2403-2407. PubMed ID: 29925480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors.
    Gökhan-Kelekçi N; Simşek OO; Ercan A; Yelekçi K; Sahin ZS; Işik S; Uçar G; Bilgin AA
    Bioorg Med Chem; 2009 Sep; 17(18):6761-72. PubMed ID: 19682910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and evaluation of β-carboline derivatives as potential monoamine oxidase inhibitors.
    Reniers J; Robert S; Frederick R; Masereel B; Vincent S; Wouters J
    Bioorg Med Chem; 2011 Jan; 19(1):134-44. PubMed ID: 21183355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A New Potent and Selective Monoamine Oxidase-B Inhibitor with Extended Conjugation in a Chalcone Framework: 1-[4-(Morpholin-4-yl)phenyl]-5-phenylpenta-2,4-dien-1-one.
    Maliyakkal N; Eom BH; Heo JH; Abdullah Almoyad MA; Thomas Parambi DG; Gambacorta N; Nicolotti O; Beeran AA; Kim H; Mathew B
    ChemMedChem; 2020 Sep; 15(17):1629-1633. PubMed ID: 32583952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-acetylphenol analogs as potent reversible monoamine oxidase inhibitors.
    Legoabe LJ; Petzer A; Petzer JP
    Drug Des Devel Ther; 2015; 9():3635-44. PubMed ID: 26203229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, in vitro, and in silico studies of 1,2,4-triazole-piperazine hybrid derivatives as potential MAO inhibitors.
    Uslu H; Osmaniye D; Sağlik BN; Levent S; Özkay Y; Benkli K; Kaplancikli ZA
    Bioorg Chem; 2021 Dec; 117():105430. PubMed ID: 34678603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of monoamine oxidase by benzoxathiolone analogues.
    Mostert S; Petzer A; Petzer JP
    Bioorg Med Chem Lett; 2016 Feb; 26(4):1200-4. PubMed ID: 26821818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and biological evaluation of N-methyl-N-[(1,2,3-triazol-4-yl)alkyl]propargylamines as novel monoamine oxidase B inhibitors.
    Di Pietro O; Alencar N; Esteban G; Viayna E; Szałaj N; Vázquez J; Juárez-Jiménez J; Sola I; Pérez B; Solé M; Unzeta M; Muñoz-Torrero D; Luque FJ
    Bioorg Med Chem; 2016 Oct; 24(20):4835-4854. PubMed ID: 27396685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2-Phenyloxazole-4-carboxamide as a Scaffold for Selective Inhibition of Human Monoamine Oxidase B.
    Di Paolo ML; Christodoulou MS; Calogero AM; Pinzi L; Rastelli G; Passarella D; Cappelletti G; Dalla Via L
    ChemMedChem; 2019 Sep; 14(18):1641-1652. PubMed ID: 31322823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoamine oxidase A and B inhibitory activities of 3,5-diphenyl-1,2,4-triazole substituted [1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives.
    Bekircan O; Danış Ö; Şahin ME; Çetin M
    Bioorg Chem; 2022 Jan; 118():105493. PubMed ID: 34814086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.